SCM
WST icon

Silvant Capital Management’s West Pharmaceutical WST Stock Holding History

Silvant Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,893
Closed -$3.59M – 314
2024
Q2 		$3.59M Hold
10,893
– – 0.16% 85
2024
Q1 		$4.31M Hold
10,893
– – 0.21% 73
2023
Q4 		$3.84M Hold
10,893
– – 0.21% 72
2023
Q3 		$4.09M Hold
10,893
– – 0.25% 64
2023
Q2 		$4.17M Buy
+10,893
New +$3.89M 0.23% 73

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Silvant Capital Management's WST Position: Q3 2024 in Review

Silvant Capital Management sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 10,893 shares — an estimated $3.59M sold.

Silvant Capital Management first reported a position in WST in Q2 2023 and held it in 5 quarters. The position peaked at $4.31M in Q1 2024. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Silvant Capital Management reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Silvant Capital Management sold 10,893 West Pharmaceutical shares in Q3 2024, an estimated $3.59M.
  • Silvant Capital Management first reported a position in West Pharmaceutical in Q2 2023 and held it in 5 quarters.
  • Silvant Capital Management's West Pharmaceutical position peaked at $4.31M in Q1 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Silvant Capital Management's 13F filing for Q3 2024, filed 29 Oct 2024.